Predictive Oncology Declares 1-for-15 Reverse Stock Split of Common Shares
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 25 2025
0mins
Source: NASDAQ.COM
Reverse Stock Split Announcement: Predictive Oncology Inc. (POAI) has announced a 1-for-15 reverse stock split of its common stock, effective September 30, 2025, where every 15 shares will be combined into one share.
Compliance with Nasdaq Requirements: The reverse stock split aims to help the company meet the minimum bid price requirement for maintaining its listing on the Nasdaq Capital Market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
